1. PRLog Home
  2. Business Index
  3. Pressroom Index
  4. Press Releases Home
  1. About
  2. Press Room
  3. Contact
Filter By Industry
Filter By Tag

Press Room

Immune Response BioPharma, Inc. Press releases

1 - 10 of 43 Press Releases

Aug 07, 2014
Immune Response BioPharma, Inc. to Develop in house Sales-Force for Blockbuster REMUNE HIV/AIDS Vaccine Commercialization

Jul 28, 2014
Immune Response BioPharma, Inc. to Seek FDA Approval for Expanded Use of Blockbuster HIV/AIDS Vaccine REMUNE for HIV/AIDS Monotherapy as it produces huge green shoots of CD8+ T cells Killer White Blood Cells

Jul 14, 2014
Immune Response BioPharma, Inc. Posts Record 1st Half 2014 Results Blockbuster HIV/AIDS Vaccine REMUNE Set to Become First HIV/AIDS Vaccine to File for FDA BLA Approval & Come to Market.

Jun 20, 2014
Immune Response BioPharma, Inc. Selects Seppic to Supply Incomplete Freund’s Adjuvants (IFA) for REMUNE HIV/AIDS Vaccine Commercialization & Pipeline

May 05, 2014
Immune Response BioPharma, Inc. to Seek FDA Breakthrough Designation of REMUNE HIV/AIDS Vaccine for Pediatric Treatment & Plans Phase II Pediatric Study.

Apr 01, 2014
Immune Response BioPharma, Inc. Announces the FDA SBA BLA Fee Waiver has been Granted & Clears a Path for the REMUNE HIV/AIDS Vaccine Approval

Mar 21, 2014
Immune Response BioPharma, Inc. Announces NeuroVax Granted Fast Track FDA Designation for SPMS

Feb 24, 2014
Immune Response BioPharma, Inc. Posts 2nd Half & Full Year 2013 Results

Feb 18, 2014
Immune Response BioPharma, Inc. Announces its Flagship HIV/AIDS Vaccine REMUNE Granted Orphan Designation for Pediatric HIV/AIDS Therapeutic Vaccination by the FDA.

Feb 09, 2014
Immune Response BioPharma, Inc. Announces its Flagship Vaccine NeuroVax Granted Orphan Designation for Pediatric MS by the FDA.


Page:

RSS Feed for Immune Response BioPharma, Inc. Press Releases